Search Results 1431-1440 of 18776 for Activation

  1. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

    Leflunomide. Any medications listed in 3 or 10 above in the post-operative period; use of Activated protein C at any time during the patients hospitalization ...

  2. Cell and Molecular Aging Laboratory - Mayo Clinic Research

    Mayo Clinic's Cell and Molecular Aging Lab, led by Joao Passos, Ph.D., focuses on senescent cells in age-related disease and mitochondria and telomeres and ...

  3. Kidney Transplant Clinical Trials - Mayo Clinic Research

    ... Activation (IA) in de Novo Kidney Transplant Recipients Scottsdale/Phoenix, AZ; Rochester, MN; Jacksonville, FL. This study will compare the incidence of a ...

  4. Debunking COVID-19 myths: Part 2 - Mayo Clinic News Network

    Some of those locations have activated hospital emergency surge plans to manage the number of patients hospitalized with COVID-19 infections. As the COVID ...

  5. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Tumors lack activating epidermal growth factor receptor (EGFR) mutations or ALK rearrangement (no EGFR or ALK testing is required if a subject has a KRAS ...

  6. Drug Combo Shuts Down Stem Cells, Tumor Growth in Lung Cancer - Mayo Clinic News Network

    Found PKCiota activates a second oncogene, known as SOX2, to stimulate cancer stem cell growth in lung squamous cell carcinoma. Dr. Fields says the current ...

  7. Parkinson's Disease Clinical Trials - Mayo Clinic Research

    This study is investigating the usefulness of using functional magnetic resonance imaging (fMRI) to monitor brain activation during deep brain stimulation for ...

  8. Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma - Mayo Clinic

    Coagulation: International Normalized Ratio (INR) < 1.5 times normal, activated Partial Thromboplastin Time (aPTT) < 1.5 times normal. Patients receiving ...

  9. A Study to Evaluate the Safety and Effectiveness of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

    AKT pathway activation is implicated in endocrine-therapy resistance. Data on the efficacy and safety of the AKT inhibitor capivasertib, as an addition to ...

  10. Progressive MS: Innovative tools for diagnosis and care - Mayo Clinic

    On a research basis, Mayo Clinic uses microglial PET scans to identify activated microglia, an important source of oxidated damage in MS. Serum and ...